Fingerprint
Dive into the research topics of 'Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer
Marise R. Heerma van Voss, Justin D. Brilliant, Farhad Vesuna, Guus M. Bol, Elsken van der Wall, Paul J. van Diest, Venu Raman*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review